HK

Hari Kant Raikwar

Director Director DIN 07322169
DIN 07322169 First appointment Mar 2016 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2016
Shareholding value Locked Premium profile

About Hari Kant Raikwar

Hari Kant Raikwar has 10 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in Healthcare. Contributes to corporate operations.

DIN 07322169
Primary Designation Director
First Appointment 04 Mar 2016
Oldest Company Age 10 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Highdrugs Healthcare Private Limited U74900DL2016PTC292137
Director 04 Mar 2016 2016 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Highdrugs Healthcare Private Limited
Premium access

Shareholding and investment profile for Hari Kant Raikwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hari Kant Raikwar

Hari Kant Raikwar has 10 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in Healthcare. Contributes to corporate operations.

Hari Kant Raikwar is associated with 0 companies as Director.

Hari Kant Raikwar has expertise in Healthcare.

Hari Kant Raikwar has 10 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available